vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Local Bounti Corporation (LOCL). Click either name above to swap in a different company.
Local Bounti Corporation is the larger business by last-quarter revenue ($12.5M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). Local Bounti Corporation runs the higher net margin — -69.8% vs -234.3%, a 164.5% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 23.7%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 21.9%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Local Bounti Corporation is a U.S.-based sustainable indoor agriculture firm growing fresh, pesticide-free leafy greens, herbs and produce via advanced hydroponic and vertical farming tech. It serves North American retail and food service partners, focusing on low environmental impact and stable year-round supply.
FHTX vs LOCL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $12.5M |
| Net Profit | $-21.7M | $-8.7M |
| Gross Margin | — | 12.2% |
| Operating Margin | -258.2% | -106.1% |
| Net Margin | -234.3% | -69.8% |
| Revenue YoY | 223.8% | 23.7% |
| Net Profit YoY | -11.1% | 76.0% |
| EPS (diluted) | $-0.35 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $12.5M | ||
| Q3 25 | $8.2M | $12.2M | ||
| Q2 25 | $7.6M | $12.1M | ||
| Q1 25 | $6.0M | $11.6M | ||
| Q4 24 | $2.9M | $10.1M | ||
| Q3 24 | $7.8M | $10.2M | ||
| Q2 24 | $6.9M | $9.4M | ||
| Q1 24 | $5.0M | $8.4M |
| Q4 25 | $-21.7M | $-8.7M | ||
| Q3 25 | $-15.8M | $-26.4M | ||
| Q2 25 | $-17.9M | $-21.6M | ||
| Q1 25 | $-18.8M | $-37.7M | ||
| Q4 24 | $-19.5M | $-36.3M | ||
| Q3 24 | $-19.1M | $-34.3M | ||
| Q2 24 | $-23.0M | $-25.3M | ||
| Q1 24 | $-25.0M | $-24.1M |
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 12.2% | ||
| Q1 25 | — | 12.6% | ||
| Q4 24 | — | 5.4% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | -258.2% | -106.1% | ||
| Q3 25 | -226.9% | -149.4% | ||
| Q2 25 | -279.2% | -127.7% | ||
| Q1 25 | -385.0% | -135.6% | ||
| Q4 24 | -840.5% | -166.6% | ||
| Q3 24 | -305.5% | -176.0% | ||
| Q2 24 | -386.6% | -146.8% | ||
| Q1 24 | -558.3% | -122.9% |
| Q4 25 | -234.3% | -69.8% | ||
| Q3 25 | -194.4% | -216.6% | ||
| Q2 25 | -237.3% | -178.3% | ||
| Q1 25 | -316.4% | -324.6% | ||
| Q4 24 | -682.9% | -360.1% | ||
| Q3 24 | -244.9% | -335.2% | ||
| Q2 24 | -333.6% | -267.6% | ||
| Q1 24 | -495.4% | -286.9% |
| Q4 25 | $-0.35 | $1.52 | ||
| Q3 25 | $-0.25 | $-1.18 | ||
| Q2 25 | $-0.28 | $-1.63 | ||
| Q1 25 | $-0.30 | $-4.32 | ||
| Q4 24 | $-0.23 | $-4.24 | ||
| Q3 24 | $-0.31 | $-4.01 | ||
| Q2 24 | $-0.45 | $-3.00 | ||
| Q1 24 | $-0.59 | $-2.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $4.2M |
| Total DebtLower is stronger | — | $483.1M |
| Stockholders' EquityBook value | $-108.5M | $-166.2M |
| Total Assets | $198.1M | $410.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $4.2M | ||
| Q3 25 | $89.3M | $6.2M | ||
| Q2 25 | $72.6M | $5.3M | ||
| Q1 25 | $61.0M | $18.0M | ||
| Q4 24 | $55.5M | $937.0K | ||
| Q3 24 | $57.7M | $317.0K | ||
| Q2 24 | $138.9M | $9.7M | ||
| Q1 24 | $79.3M | $8.2M |
| Q4 25 | — | $483.1M | ||
| Q3 25 | — | $484.9M | ||
| Q2 25 | — | $478.3M | ||
| Q1 25 | — | $480.0M | ||
| Q4 24 | — | $436.8M | ||
| Q3 24 | — | $398.4M | ||
| Q2 24 | — | $374.0M | ||
| Q1 24 | — | $329.8M |
| Q4 25 | $-108.5M | $-166.2M | ||
| Q3 25 | $-89.7M | $-158.1M | ||
| Q2 25 | $-76.7M | $-132.7M | ||
| Q1 25 | $-61.7M | $-134.5M | ||
| Q4 24 | $-45.5M | $-100.5M | ||
| Q3 24 | $-28.3M | $-65.6M | ||
| Q2 24 | $-14.3M | $-32.8M | ||
| Q1 24 | $-97.5M | $-9.4M |
| Q4 25 | $198.1M | $410.5M | ||
| Q3 25 | $205.0M | $417.8M | ||
| Q2 25 | $226.2M | $426.8M | ||
| Q1 25 | $258.7M | $447.2M | ||
| Q4 24 | $284.0M | $428.0M | ||
| Q3 24 | $308.4M | $430.8M | ||
| Q2 24 | $328.6M | $438.1M | ||
| Q1 24 | $255.0M | $413.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-3.1M |
| Free Cash FlowOCF − Capex | — | $-3.6M |
| FCF MarginFCF / Revenue | — | -29.1% |
| Capex IntensityCapex / Revenue | 0.0% | 3.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-42.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-3.1M | ||
| Q3 25 | $-18.9M | $-8.9M | ||
| Q2 25 | $-21.0M | $-8.7M | ||
| Q1 25 | $-24.0M | $-9.6M | ||
| Q4 24 | $-24.5M | $1.2M | ||
| Q3 24 | $-21.0M | $-17.2M | ||
| Q2 24 | $-25.5M | $-4.0M | ||
| Q1 24 | $-29.3M | $-7.1M |
| Q4 25 | — | $-3.6M | ||
| Q3 25 | — | $-10.1M | ||
| Q2 25 | $-21.0M | $-14.6M | ||
| Q1 25 | $-24.0M | $-14.5M | ||
| Q4 24 | $-25.0M | $-8.6M | ||
| Q3 24 | $-21.3M | $-30.0M | ||
| Q2 24 | $-25.6M | $-28.8M | ||
| Q1 24 | $-29.4M | $-42.1M |
| Q4 25 | — | -29.1% | ||
| Q3 25 | — | -82.8% | ||
| Q2 25 | -278.2% | -121.0% | ||
| Q1 25 | -403.2% | -125.1% | ||
| Q4 24 | -875.3% | -85.3% | ||
| Q3 24 | -273.0% | -293.1% | ||
| Q2 24 | -371.0% | -305.4% | ||
| Q1 24 | -583.1% | -501.8% |
| Q4 25 | 0.0% | 3.9% | ||
| Q3 25 | 0.0% | 9.7% | ||
| Q2 25 | 0.3% | 48.9% | ||
| Q1 25 | 0.5% | 42.8% | ||
| Q4 24 | 16.8% | 97.6% | ||
| Q3 24 | 4.0% | 125.0% | ||
| Q2 24 | 0.2% | 263.0% | ||
| Q1 24 | 2.0% | 417.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
